Scarica l'app Stockscreener
12.68
6.21%
-0.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NXTC Giù?
Forum
Previsione
Precedente Chiudi:
$13.52
Aprire:
$13.725
Volume 24 ore:
22,918
Relative Volume:
0.64
Capitalizzazione di mercato:
$44.45M
Reddito:
-
Utile/perdita netta:
$-55.84M
Rapporto P/E:
-0.7207
EPS:
-17.5951
Flusso di cassa netto:
$-49.61M
1 W Prestazione:
+2.34%
1M Prestazione:
-3.21%
6M Prestazione:
+135.00%
1 anno Prestazione:
+1,661%
Intervallo 1D:
$12.66
$14.36
Intervallo di 1 settimana:
$12.29
$14.36
Portata 52W:
$0.224
$15.74
Nextcure Inc Stock (NXTC) Company Profile
Nome
Nextcure Inc
Settore
Industria
Telefono
240-399-4900
Indirizzo
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
12.68 | 44.45M | 0 | -55.84M | -49.61M | -17.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2022-11-04 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-03-05 | Aggiornamento | Truist | Hold → Buy |
| 2021-01-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Downgrade | SunTrust | Buy → Hold |
| 2020-06-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-03-24 | Iniziato | The Benchmark Company | Buy |
| 2020-03-02 | Iniziato | ROTH Capital | Buy |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-12-05 | Iniziato | Needham | Buy |
| 2019-11-26 | Iniziato | BTIG Research | Buy |
| 2019-07-09 | Iniziato | BofA/Merrill | Buy |
| 2019-06-03 | Iniziato | Morgan Stanley | Overweight |
| 2019-06-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Nextcure Inc Borsa (NXTC) Ultime notizie
NextCure Inc Stock (ISIN: US65343E1082) Faces Analyst Downgrade Amid Biotech Sector Headwinds - AD HOC NEWS
NextCure 10-K: $0 Revenue, $(19.65) EPS reported - TradingView
NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NextCure Provides Business Update and Reports Full Year 2025 Financial Results - The Manila Times
Cancer drug developer NextCure maps 2026 trial milestones and funding runway - Stock Titan
NXTC SEC FilingsNextcure 10-K, 10-Q, 8-K Forms - Stock Titan
NextCure, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NextCure Inc expected to post a loss of $2.42 a shareEarnings Preview - TradingView
Hedge Fund Bets: Is NextCure Inc stock good for income investorsJuly 2025 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
NextCure (NXTC) Projected to Post Quarterly Earnings on Thursday - Defense World
Published on: 2026-02-26 09:55:29 - baoquankhu1.vn
NextCure (NASDAQ:NXTC) Stock Price Down 3.7% – What’s Next? - Defense World
Can NextCure Inc. stock double in next 5 yearsWeekly Investment Report & Technical Entry and Exit Tips - mfd.ru
Squadron funds disclose 9.99% holding in NextCure (NXTC) common stock - Stock Titan
Will The Allstate Corporation stock benefit from green energy trendsIPO Watch & Weekly Return Optimization Alerts - mfd.ru
NXTC Technical Analysis & Stock Price Forecast - Intellectia AI
Is FSLR stock a top pick in earnings seasonMarket Trend Summary & Precise Swing Trade Alerts - mfd.ru
Street Watch: Is NextCure Inc stock showing strong momentumGap Down & Community Verified Trade Signals - baoquankhu1.vn
Cancer index surges 72% as Terns, Olema lead gains - BioWorld MedTech
Aug Catalysts: Is NextCure Inc stock showing strong momentumJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Fund Flows: What is LanzaTech Global Inc. Equity Warrant s revenue forecastMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
NextCure provides updates on ADC programs, reports cash position By Investing.com - Investing.com South Africa
NextCure Provides Business Update - citybiz
NextCure Updates ADC Pipeline Progress and Cash Runway - TipRanks
Next Cure Highlights Progress Across ADC Pipeline As Company Extends Cash Runway Into 2027 - Nasdaq
NextCure provides updates on ADC programs, reports cash position - Investing.com
NextCure provides business update - marketscreener.com
NextCure Provides Business Update - GlobeNewswire Inc.
NXTC: SIM0505 and LNCB74 advance in Phase 1, with strong efficacy and key data expected in 2026 - TradingView
Is Concord Medical Services Holdings Limited stock included in top ETFsJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Market Outlook: What’s the RSI of ON24 Inc. stockJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Buyout Rumor: Can NextCure Inc stock deliver 10 annual returnsWeekly Risk Summary & Safe Entry Point Identification - Bộ Nội Vụ
Aug Setups: How liquid is NextCure Inc stockPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
What margin trends mean for NextCure Inc. stock2025 Institutional Moves & Stock Timing and Entry Methods - Улправда
Will NextCure Inc. stock remain a Wall Street favorite2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru
Will Banzai International Inc. Equity Warrant stock deliver better than expected guidance - Улправда
Will NextCure Inc. stock maintain growth storyMarket Activity Report & Scalable Portfolio Growth Methods - Улправда
Will NextCure Inc. stock benefit from automation2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
How analysts revise price targets for XYZY stockEarnings Beat & Free Real-Time Volume Trigger Notifications - Улправда
Will CO2 Energy Transition Corp. Equity Right stock outperform international peers2025 Price Targets & Low Drawdown Trading Strategies - ulpravda.ru
Why Intellinetics Inc. stock is trending among retail tradersLayoff News & Technical Buy Zone Confirmation - Улправда
How institutional buying supports NextCure Inc. stock2025 EndofYear Setup & Daily Profit Focused Screening - Улправда
Is NextCure Inc. stock resilient to inflationBull Run & High Yield Equity Trading Tips - Улправда
Risk Off: Why retail investors favor DRVN stock2025 AllTime Highs & Short-Term Trading Opportunity Alerts - moha.gov.vn
NextCure stock plunges to 52-week low, hits $0.69 - MSN
The Truth About NextCure Inc (NXTC): Hidden Biotech Underdog or Total Flop Stock? - AD HOC NEWS
Machinery Limited Builds Base for Possible ReboundFundamental Strength Indicators & Explosive Profit Growth - bollywoodhelpline.com
Options Data Show Bullish Bias in Foseco India LimitedValue Traps to Avoid & Explosive Profit Trading - bollywoodhelpline.com
Biocon Limited (BIOCON) vs yyyLong-Term Growth Stocks & Minimal Capital Growth Ideas - bollywoodhelpline.com
Jewellery Limited (LYPSAGEMS) Hits 52 Week HighDividend Stability Analysis & High Profit Investment Ideas - bollywoodhelpline.com
Nextcure Inc Azioni (NXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):